Form EFFECT KIORA PHARMACEUTICALS
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 22, 2026 4:30 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kiora Pharmaceuticals to Participate in Piper Sandler Virtual Ophthalmology Symposium
- Brødrene A. & O. Johansen A/S announces a recommended voluntary cash offer of NOK 22 per share to the shareholders of Elektroimportøren AS and publishes offer document; commencement of offer period
- Hepsor signs loan agreement with Coop Pank and starts construction of new residential buildings in Paevälja
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
